Clinical Trial Update: Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update evaluating the efficacy of house dust mite immunotherapy in children with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• House Dust Mite Immunotherapy (house dust mite allergen extract)

Snippet

Sponsor: Medical University of Lodz | Conditions: Asthma | Phase 4 | Status: UNKNOWN